Anagliptin
Showing 1 - 8 of 8
Type 2 Diabetes Trial in Seoul (Anagliptin BID Treatment)
Completed
- Type 2 Diabetes
- Anagliptin BID Treatment
-
Seoul, Korea, Republic ofKangdong Sacred Heart Hospital
Mar 22, 2021
Efficacy and Safety of Anagliptin Switching From Other DPP4is in
Active, not recruiting
- Type 2 Diabetes Mellitus
- Anagliptin
-
Bucheon, Korea, Republic ofThe Catholic University of Korea, Bucheon ST. Mary's hopsital
Apr 28, 2021
Dipeptidyl-Peptidase 4 Inhibitors, LDL Cholesterol, Glycosylated Hemoglobin Trial in Tomishiro (Anagliptin, Sitagliptin)
Completed
- Dipeptidyl-Peptidase 4 Inhibitors
- +4 more
- Anagliptin
- Sitagliptin
-
Tomishiro, Okinawa, JapanDepartment of Cardiovascular Medicine, Tomishiro Central Hospita
Aug 22, 2019
Heart Failure, Diabetes Trial in Taito-ku (Suspending DPP-4 inhibitor, in outpatient service, Starting DPP-4 inhibitor after
Completed
- Heart Failure
- Diabetes Mellitus
- Suspending DPP-4 inhibitor, in outpatient service
- +2 more
-
Taito-ku, Tokyo, JapanMitsui Memorial Hospital
Mar 20, 2018
Type 2 Diabetes Trial in Japan (Trelagliptin, Daily DPP-4 inhibitor)
Completed
- Type 2 Diabetes
- Trelagliptin
- Daily DPP-4 inhibitor
-
Nagoya, Aichi, Japan
- +26 more
Feb 25, 2019
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Trial in Kurume city
Unknown status
- Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
- DPP-4 inhibiotors
- +2 more
-
Kurume city, JapanKurume University Hospital
Aug 18, 2015
Type 2 Diabetes Trial in Seoul (Anagliptin, Sitagliptin)
Completed
- Type 2 Diabetes Mellitus
- Anagliptin
- Sitagliptin
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
May 12, 2014
Type 2 Diabetes Trial in Seoul (Anagliptin, Placebo of Anagliptin)
Completed
- Type 2 Diabetes Mellitus
- Anagliptin
- Placebo of Anagliptin
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Jan 2, 2013